In 2012 a study was conducted which established a link between the statin class of medications and the development of Type 2 Diabetes in women, predominantly post-menopausal women.
Subsequently, numerous Lipitor lawsuits have been filed in the USA against pharmaceutical corporation, Pfizer, claiming that Pfizer failed to adequately warn consumers of the risk of developing diabetes associated with the statin.
What is Lipitor?
Lipitor is a cholesterol-lowering drug which reduces blood levels of low density lipoprotein (LDL) cholesterol and belongs to the class of drugs called statins. In 1996, the US Food and Drug Administration (FDA) approved the product and it is one of the world's top-selling prescription drugs.
What is Lipitor used for?
The medication is frequently prescribed by doctors:-
Other side effects linked to Lipitor:
What does Pfizer have to say about this?
In February 2012, only after a request by the FDA, Pfizer finally agreed to update and communicate the drug's association to high blood sugar and increased risk of diabetes on its labelling.
However, the warning does not mention Type 2 Diabetes. Instead the warning labels state: “Increases in HbA1c and fasting serum glucose levels have been reported with HMG-CoA reductase inhibitors, including LIPITOR.”
Several victims are proceeding to file lawsuits against Pfizer in an attempt to obtain compensation for suffering serious side effects from using Lipitor.
Claimants are alleging that Pfizer: